LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to keep advanced breast cancer at bay longer
Disease control OngoingThis large, late-stage trial is testing whether adding a new drug called giredestrant to a standard two-drug therapy (Phesgo) helps people with a specific type of advanced breast cancer live longer without their cancer getting worse. The study involves over 900 adults with HER2-p…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New drug combo tested for Tough-to-Treat breast cancer
Disease control OngoingThis study is testing whether adding a new drug called capivasertib to an existing hormone therapy (fulvestrant) can help control advanced breast cancer that has specific genetic changes and has started growing again after standard treatments. It will involve about 101 patients i…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC